Grant Boldt
Chief Operating Officer CPTx
Seminars
Wednesday 25th February 2026
Panel Discussion: Leveraging AI & Machine Learning to Accelerate R&D & Construct Design
2:40 pm
- Explore how AI-driven tools are being applied to design next- generation receptor constructs with improved precision and functionality
- Discuss the use of machine learning in identifying novel targets and accelerating preclinical discovery
- Highlight the challenges of obtaining sufficient, high-quality datasets
Thursday 26th February 2026
Non Viral In-Vivo CAR – Engineering with Episomal DNA: The Next Frontier for Off-the-Shelf & Scalable Cell Therapy
3:30 pm
- Creating a third path to in-vivo CAR-T
- Highlight emerging preclinical evidence demonstrating feasibility and efficacy
New Data
